China’s AI-driven drug firms are expanding globally despite U.S. scrutiny. They secured $93 billion in licensing deals in 2026, a significant rise. Metis TechBio struck a...
China’s decision to set a reduced GDP growth target of 4.5–5.0 per cent for 2026 marks another step in a long-running structural transition. Chinese policymakers have...
Chinese researchers’ discovery of endangered hawksbill sea turtles near Scarborough Shoal serves strategic purposes, reinforcing China’s claims in contested South China Sea waters. Such scientific activities...